Stopping gout medication based on ultrasound results
Part of Bones, joints & muscles clinical trials.
This study looks at whether people with gout whose uric acid is well controlled and whose joints are clear on ultrasound can safely stop their daily uric acid-lowering medication. Participants are randomly assigned to either continue their current medication or stop it, and their health is monitored to see if stopping leads to gout flares or joint damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a confirmed diagnosis of gout.
- You have not had a gout flare for at least 2 years.
- You do not have any tophi (hard lumps of uric acid under the skin).
- You have been taking allopurinol or febuxostat for at least 2 years and your uric acid level is well controlled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.
This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.
This study tests whether a pharmacist can help veterans with gout manage their uric acid levels using standard medications, aiming to reduce gout flares. If you've had a gout flare recently and are starting or already taking uric acid-lowering medicine, this might be a good fit.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
Hear when a new Gout Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.